# Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

> **NCT04355026** · PHASE4 · UNKNOWN · sponsor: **General and Teaching Hospital Celje** · enrollment: 90 (estimated)

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** Bromhexine Oral Tablet and/or hydroxychloroquine tablet

## Key facts

- **NCT ID:** NCT04355026
- **Lead sponsor:** General and Teaching Hospital Celje
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-10
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-07-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355026, "Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04355026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*